ConductScience.org, home

Paper3929314

Tyramine pressor sensitivity changes during deprenyl treatment.

Sunderland T and 5 others. Psychopharmacology (Berl), 1985. Cited by 76 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Tyramine pressor sensitivity changes during deprenyl treatment. Papers, record 3929314. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3929314

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tyramine pressor sensitivity changes during deprenyl treatment.
PubMed
Journal
Psychopharmacology (Berl)
PubMed
Year
1985
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
76
iCite
Relative citation ratio, by iCite
3.38
iCite
Revised in PubMed
2026-10-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sunderland TT
2Mueller EAE A
3Cohen RMR M
4Jimerson DCD C
5Pickar DD
6Murphy DLD L

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood PressureMajor topic
PhenethylaminesMajor topic
SelegilineMajor topic
TyramineMajor topic
Dose-Response Relationship, Drug
Humans
Methoxyhydroxyphenylglycol
Monoamine Oxidase

Source PubMed

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,207,877Selective monoamine oxidase inhibitor drugs as aids in evaluating the role of type A and B enzymes.Neuropharmacology1975https://conductscience.org/library/papers/1207877PubMed
24,943,186Interactions between sympathomimetic amines and a new monoamine oxidase inhibitor.Psychopharmacologia1970https://conductscience.org/library/papers/4943186PubMed
349,518Intravenous tyramine pressor response in depression.Lancet1975https://conductscience.org/library/papers/49518PubMed
46,284,529Cardiovascular changes in response to selective monoamine oxidase inhibition in the rat.Eur J Pharmacol1982https://conductscience.org/library/papers/6284529PubMed
5111,274Comparative behavioral effects of clorgyline and pargyline in man: a preliminary evaluation.Psychopharmacology (Berl)1979https://conductscience.org/library/papers/111274PubMed
614,163,106MONOAMINE OXIDASE INHIBITORS, TYRAMINE, AND CHESSE.JAMA1964https://conductscience.org/library/papers/14163106PubMed
77,260,342Simultaneous measurement of plasma 4-hydroxy-3-methoxyphenylethylene glycol and 3,4-dihydroxyphenylethylene glycol by gas chromatography mass spectrometry.Biomed Mass Spectrom1981https://conductscience.org/library/papers/7260342PubMed
86,814,755(-)Deprenyl in the treatment of Parkinson's disease.Clin Neuropharmacol1982https://conductscience.org/library/papers/6814755PubMed
96,768,943L-deprenyl, a selective monoamine oxidase type-B inhibitor in endogenous depression.Life Sci1980https://conductscience.org/library/papers/6768943PubMed
106,791,210Tyramine infusions and selective monoamine oxidase inhibitor treatment. II. Interrelationships among pressor sensitivity changes, platelet MAO inhibition, and plasma MHPG reduction.Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6791210PubMed
11708,454Novel (-)deprenyl-derived selective inhibitors of B-type monoamine oxidase. The relation of structure to their action.Biochem Pharmacol1978https://conductscience.org/library/papers/708454PubMed
1271,602Deprenyl in Parkinson's disease.Lancet1977https://conductscience.org/library/papers/71602PubMed
134,947,578Interactions of monoamine oxidase inhibitors, amines, and foodstuffs.Adv Pharmacol Chemother1970https://conductscience.org/library/papers/4947578PubMed
146,791,202Tyramine infusions and selective monoamine oxidase inhibitor treatment. I. Changes in pressor sensitivity.Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6791202PubMed
15834,248Dopamine is a monoamine oxidase B substrate in man.Nature1977https://conductscience.org/library/papers/834248PubMed
16745,013Absence of "cheese effect" during deprenyl therapy: some recent studies.J Neural Transm1978https://conductscience.org/library/papers/745013PubMed
176,056,555Clinical trial of a new type promptly acting psychoenergetic agent (phenyl-isopropyl-methylpropinyl-HCl, "E-250").Acta Med Acad Sci Hung1967https://conductscience.org/library/papers/6056555PubMed
186,785,797Is the failure of (-)deprenyl, a selective monoamine oxidase B inhibitor, to alleviate depression related to freedom from the cheese effect?Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6785797PubMed
19656,120Deprenil: loss of selectivity for inhibition of B-type MAO after repeated treatment.Biochem Pharmacol1978https://conductscience.org/library/papers/656120PubMed
20495,801Tyramine infusions in bipolar illness: behavioral effects and longitudinal changes in pressor sensitivity.Am J Psychiatry1979https://conductscience.org/library/papers/495801PubMed

See all 38 references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.

PMIDTitleJournalYearIn PapersSource
32,574,581The role of monoamine oxidase A in the neurobiology of aggressive, antisocial, and violent behavior: A tale of mice and men.Prog Neurobiol2020https://conductscience.org/library/papers/32574581PubMed
25,249,059Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain.Neuropsychopharmacology2015https://conductscience.org/library/papers/25249059PubMed
23,934,742Current place of monoamine oxidase inhibitors in the treatment of depression.CNS Drugs2013https://conductscience.org/library/papers/23934742PubMed
18,728,814Depression in Parkinson's disease: health risks, etiology, and treatment options.Neuropsychiatr Dis Treat2008https://conductscience.org/library/papers/18728814PubMed
18,311,418A review of the literature on the selegiline transdermal system: an effective and well-tolerated monoamine oxidase inhibitor for the treatment of depression.Prim Care Companion J Clin Psychiatry2008https://conductscience.org/library/papers/18311418PubMed
10,050,962Screen for MAOA mutations in target human groups.Am J Med Genet1999https://conductscience.org/library/papers/10050962PubMed
9,673,855Safety of selegiline (deprenyl) in the treatment of Parkinson's disease.Drug Saf1998https://conductscience.org/library/papers/9673855PubMed
9,285,463Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease.J Neurol Neurosurg Psychiatry1997https://conductscience.org/library/papers/9285463PubMed
8,857,072Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline.Eur J Clin Pharmacol1996https://conductscience.org/library/papers/8857072PubMed
8,613,523Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes.J Clin Invest1996https://conductscience.org/library/papers/8613523PubMed
8,136,085Comparative tolerability profiles of the newer versus older antidepressants.Drug Saf1994https://conductscience.org/library/papers/8136085PubMed
3,145,523Enhanced pressor sensitivity to oral tyramine challenge following high dose selegiline treatment.Psychopharmacology (Berl)1988https://conductscience.org/library/papers/3145523PubMed
3,114,792Marked enhancement by clorgyline of nocturnal and daytime melatonin release in rhesus monkeys.Psychopharmacology (Berl)1987https://conductscience.org/library/papers/3114792PubMed
2,436,247Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease.Psychopharmacology (Berl)1987https://conductscience.org/library/papers/2436247PubMed
1,794,016Selegiline. A review of its pharmacology, symptomatic benefits and protective potential in Parkinson's disease.Drugs Aging1991https://conductscience.org/library/papers/1794016PubMed

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MAOA4,128PubTator's text mininghttps://conductscience.org/library/genes/4128NCBI Gene
MAOB4,129PubTator's text mininghttps://conductscience.org/library/genes/4129NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3929314

GET https://conductscience.org/api/papers/v1/3929314/references?page=2